Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy BPC 157 FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Gray Market Peptides: So Much Hype, So Little Data